ALPS Medical Breakthroughs ETF SBIO
52.53 USD -0.37 (-0.71%)
Regular-session close
52.53 0.00 0.00%
Pre-market · Nov 20, 4:00 AM ET
52.25 Day range 53.85
45.65 52-week range 70.85
- YTD
- +2.56%
- 1 year
- +14.00%
5D -4.17 (-7.23%)
- Assets
- $180.57M
- Expense ratio
- 0.50%
- NAV
- 53.90
- Holdings
- 103
- Top 10 weight
- 32.7%
- Asset class
- Equity
- Issuer
- ALPS Funds
- Inception
- Dec 30, 2014
- YTD return
- +2.56%
- 1-year return
- +14.00%
- Volume
- 62.08K
- Avg volume
- 35.54K
- Open
- 53.19
- Previous close
- 52.90
- Day's range
- 52.25 – 53.85
- 52-week range
- 45.65 – 70.85
- 50-day average
- 38.30
- 200-day average
- 35.94
About ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SBIO — it syncs with the Stock Master app.
